Patent ID: 11945790
Assignee: IMMUNOMOLECULAR THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 0:
1. A pharmaceutical composition comprising a compound of Formula (I),, , or a pharmaceutically acceptable salt thereof, wherein
Ar is optionally substituted phenyl;
R1 is R5O—(CH2)n—, R5S(O)q—(CH2)n—, or R5N(R)—(CH2)n;
n is 1, 2, 3 or 4;
p is 0 or 2;
q is 0, 1 or 2;
R8 is selected from the group consisting of hydrogen, halogen and optionally substituted C1-C6-alkyl;
R9 and R10 are each hydrogen;
when p is 2, the two R11 groups are nonadjacent and nongeminal and together form a bridging C2-C4-alkylene or C2-C4-alkenylene group;
R5 is optionally substituted C3-C8-cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl or optionally substituted heteroaryl; and
R is H, optionally substituted C3-C6-cycloalkyl, or optionally substituted C1-C6-alkyl; and a pharmaceutically acceptable carrier or excipient.